Anke Rauterkus-Hennig
Chief Executive Officer at RESAPHENE SUISSE AG
Profile
Anke Rauterkus-Hennig is currently the Chairman & Chief Executive Officer of Resaphene Suisse AG and the Director of Bs Health Group AG since 2012.
Anke Rauterkus-Hennig active positions
| Companies | Position | Start |
|---|---|---|
| RESAPHENE SUISSE AG | Chief Executive Officer | - |
Bs Health Group AG
 Bs Health Group AG Investment ManagersFinance Bs Health Group AG operates as a Swiss venture capital company. The private company is based in Roggwil, Switzerland. | Director/Board Member | 2011-12-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Resaphene Suisse AG
 Resaphene Suisse AG Medical SpecialtiesHealth Technology Resaphene Suisse AG operates as a medical technology company. It has been selling a tinnitus therapy device under the name tinniwell. The company was founded on 2015 and is headquartered in Roggwil, Switzerland. | Health Technology |
Bs Health Group AG
Bs Health Group AG Investment ManagersFinance Bs Health Group AG operates as a Swiss venture capital company. The private company is based in Roggwil, Switzerland. | Finance |
- Stock Market
- Insiders
- Anke Rauterkus-Hennig